Allelic Loss on Chromosome Arm 8p: Analysis of Sporadic Epithelial Ovarian Tumors

Objective. Our objective was to determine the frequency of allelic loss at 8p21 in sporadic epithelial ovarian cancer. We recently described allelic loss at this locus in 7/9 ovarian cancers from patients with BRCA1 gene mutations. Methods. We anonymously obtained and examined 40 unselected invasive...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 1999-07, Vol.74 (1), p.98-102
Main Authors: Brown, Monica R., Chuaqui, Rodrigo, Vocke, Cathy D., Berchuck, Andrew, Middleton, Lavinia P., Emmert-Buck, Michael R., Kohn, Elise C.
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Chromosomes, Human, Pair 8 - genetics
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Loss of Heterozygosity
Medical sciences
Middle Aged
Ovarian Neoplasms - genetics
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. Our objective was to determine the frequency of allelic loss at 8p21 in sporadic epithelial ovarian cancer. We recently described allelic loss at this locus in 7/9 ovarian cancers from patients with BRCA1 gene mutations. Methods. We anonymously obtained and examined 40 unselected invasive epithelial ovarian cancers and 5 low-malignant-potential (LMP) ovarian tumors for loss of heterozygosity (LOH) at 8p12–22. Pure epithelial and stromal cell populations were procured selectively by laser capture microdissection and extracted DNA was amplified with polymorphic microsatellite markers spanning the region of interest. Results. LOH was highest (50%) at marker D8S136 located at 8p21 with 15 of 30 informative cases exhibiting an allelic deletion. None of the LMP tumors evaluated showed LOH at 8p12–22. A trend toward more frequent LOH at 8p12–22 was identified with increasing disease aggressiveness from LMP to early stage invasive ovarian cancer to advanced stage invasive ovarian cancer (Lehman's test, P2 < 0.024). Conclusions. Fifty percent allelic loss at the distal portion of 8p21 has not been reported to date for sporadic epithelial ovarian carcinomas. The higher rate of loss in our cohort, in contrast to previous allelotyping studies, is due likely to analysis from homogenous cell populations. These results, in concert with our previous study of BRCA1 mutation-positive patients, suggest a tumor suppressor gene locus at 8p21 for epithelial ovarian cancer.
ISSN:0090-8258
1095-6859
DOI:10.1006/gyno.1999.5439